The implications of resistance to CCR5 antagonists with respect to other antiretroviral agents has not been well described; however, one report evaluated the implications in vitro and demonstrated that resistance to CCR5 inhibitors may increase the sensitivity of the resistant virus to certain neutralizing antibodies [106].